Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-13052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-867 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-45 |
filingDate |
1998-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2001-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2001514235-A |
titleOfInvention |
Compositions and methods for treating arthritis utilizing gene therapy |
abstract |
(57) SUMMARY Methods are provided for treating or preventing arthritis. The method includes the general step of administering to a mammal a therapeutically effective amount of a retroviral vector that directs the expression of an anti-arthritic agent, wherein the retroviral vector has a titer greater than 10 7 cfu / ml. Is administered. |
priorityDate |
1997-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |